Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)
India · Delayed Price · Currency is INR 819.00
-7.05 (-0.85%)
Jul 31, 2026, 3:29 PM IST
NSE:YATHARTH Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 12,072 | 8,805 | 6,705 | 5,203 | 4,009 |
Other Revenue | 257.87 | 51.6 | 26.92 | 21.96 | 9.34 |
| 12,330 | 8,856 | 6,732 | 5,225 | 4,019 | |
Revenue Growth | 39.22% | 31.55% | 28.85% | 30.01% | 75.74% |
Cost of Revenue | 4,692 | 3,410 | 2,503 | 1,849 | 1,618 |
Gross Profit | 7,638 | 5,446 | 4,229 | 3,376 | 2,401 |
Selling, General & Admin | - | 228.1 | 73.14 | 63.38 | 29.46 |
Other Operating Expenses | 4,459 | 2,961 | 2,327 | 1,951 | 1,253 |
Operating Expenses | 5,337 | 3,761 | 2,693 | 2,290 | 1,561 |
Operating Income | 2,301 | 1,685 | 1,536 | 1,086 | 839.53 |
Interest Expense | -65.35 | -75.11 | -94.18 | -213.87 | -214.86 |
Interest & Investment Income | - | 78.48 | 126.91 | 4.28 | 6.4 |
Other Non Operating Income (Expenses) | - | - | 0.02 | - | -0.02 |
EBT Excluding Unusual Items | 2,236 | 1,688 | 1,568 | 876.78 | 631.05 |
Gain (Loss) on Sale of Investments | - | 28.9 | - | - | - |
Pretax Income | 2,236 | 1,717 | 1,568 | 876.78 | 631.05 |
Income Tax Expense | 532.55 | 411.89 | 423.58 | 219.1 | 189.43 |
Earnings From Continuing Operations | 1,703 | 1,306 | 1,145 | 657.68 | 441.62 |
Minority Interest in Earnings | 50.75 | - | - | - | - |
Net Income | 1,754 | 1,306 | 1,145 | 657.68 | 441.62 |
Net Income to Common | 1,754 | 1,306 | 1,145 | 657.68 | 441.62 |
Net Income Growth | 34.34% | 14.04% | 74.06% | 48.92% | 143.18% |
Shares Outstanding (Basic) | 96 | 89 | 79 | 66 | 66 |
Shares Outstanding (Diluted) | 96 | 89 | 79 | 66 | 66 |
Shares Change | 8.67% | 11.86% | 20.99% | - | - |
EPS (Basic) | 18.20 | 14.72 | 14.44 | 10.04 | 6.74 |
EPS (Diluted) | 18.20 | 14.72 | 14.44 | 10.04 | 6.74 |
EPS Growth | 23.64% | 1.93% | 43.86% | 48.92% | 143.34% |
Free Cash Flow | -1,120 | -1,612 | -964.43 | 439.7 | 468.01 |
Free Cash Flow Per Share | -11.63 | -18.18 | -12.17 | 6.71 | 7.14 |
Gross Margin | 61.95% | 61.49% | 62.82% | 64.62% | 59.74% |
Operating Margin | 18.66% | 19.03% | 22.81% | 20.79% | 20.89% |
Profit Margin | 14.22% | 14.74% | 17.00% | 12.59% | 10.99% |
Free Cash Flow Margin | -9.09% | -18.20% | -14.32% | 8.42% | 11.65% |
EBITDA | 3,179 | 2,231 | 1,808 | 1,340 | 1,097 |
EBITDA Margin | 25.78% | 25.19% | 26.85% | 25.65% | 27.31% |
D&A For EBITDA | 878.06 | 545.88 | 271.94 | 254 | 257.92 |
EBIT | 2,301 | 1,685 | 1,536 | 1,086 | 839.53 |
EBIT Margin | 18.66% | 19.03% | 22.81% | 20.79% | 20.89% |
Effective Tax Rate | 23.82% | 23.98% | 27.01% | 24.99% | 30.02% |
Revenue as Reported | 12,330 | 8,967 | 6,862 | 5,231 | 4,026 |